Global Plasma Protease C1-inhibitor Treatment Market Research Report 2015-2025
- HEY3832919
- 77 Pages
- April 2020
- Healthcare
The global Plasma Protease C1-inhibitor Treatment market will reach xxx Million USD in 2020 with CAGR xx% 2020-2025. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
Based on Drug Class, the report describes major products type share of regional market. Products mentioned as follows:
C1-inhibitors
Kallikrein Inhibitor (Kalbitor)
Selective Bradykinin B2 Receptor Antagonist (Firazyr)
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
Shire plc
CSL Limited
Sanquin
Pharming Group N.V.
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
Hospital Pharmacies
Independent Pharmacies and Outlets
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
Asia-Pacific
North America
Europe
South America
Middle East & Africa
1 Market Overview
1.1 Objectives of Research
1.1.1 Definition
Figure Plasma Protease C1-inhibitor Treatment Picture
1.1.2 Specifications
Table Product Specifications of Plasma Protease C1-inhibitor Treatment
1.2 Market Segment
1.2.1 by Drug Class
Table Products Segment of Plasma Protease C1-inhibitor Treatment
Table Global Plasma Protease C1-inhibitor Treatment Market by Type, 2011-2022 (USD Million)
1.2.1.1 C1-inhibitors
Table C1-inhibitors Overview
1.2.1.2 Kallikrein Inhibitor (Kalbitor)
Table Kallikrein Inhibitor (Kalbitor) Overview
1.2.1.3 Selective Bradykinin B2 Receptor Antagonist (Firazyr)
Table Selective Bradykinin B2 Receptor Antagonist (Firazyr) Overview
1.2.2 by Application
Table Application Segment of Plasma Protease C1-inhibitor Treatment
Table Global Plasma Protease C1-inhibitor Treatment Market by Application, 2011-2022 (USD Million)
1.2.2.1 Hospital Pharmacies
Table Hospital Pharmacies Overview
1.2.2.2 Independent Pharmacies and Outlets
Table Independent Pharmacies and Outlets Overview
1.2.3 by Regions
Table Global Plasma Protease C1-inhibitor Treatment Market by Region, 2011-2022 (USD Million)
2 Industry Chain
2.1 Industry Chain Structure
Figure Industry Chain Structure of Plasma Protease C1-inhibitor Treatment
2.2 Upstream
Table Cost of Plasma Protease C1-inhibitor Treatment
Figure Manufacturing Process of Plasma Protease C1-inhibitor Treatment
2.3 Market
2.3.1 SWOT
Figure SWOT of Plasma Protease C1-inhibitor Treatment
2.3.2 Dynamics
Table Market Dynamics
3 Environmental Analysis
3.1 Policy
Table Policy of Plasma Protease C1-inhibitor Treatment
3.2 Economic
Table GDP of Major Countries
3.3 Technology
Table Technology of Plasma Protease C1-inhibitor Treatment
3.4 Market Entry
Table Market Entry of Plasma Protease C1-inhibitor Treatment
4 Market Segmentation by Type
4.1 Market Size
4.1.1 C1-inhibitors Market, 2013-2018
Figure C1-inhibitors Market Size and Growth, 2015-2019 (USD Million)
Figure C1-inhibitors Market Size and Growth, 2015-2019 (in Volume)
Table C1-inhibitors CAGR by Revenue and Volume, 2015-2019
4.1.2 Kallikrein Inhibitor (Kalbitor) Market, 2013-2018
Figure Kallikrein Inhibitor (Kalbitor) Market Size and Growth, 2015-2019 (USD Million)
Figure Kallikrein Inhibitor (Kalbitor) Market Size and Growth, 2015-2019 (in Volume)
Table Kallikrein Inhibitor (Kalbitor) CAGR by Revenue and Volume, 2015-2019
4.1.3 Selective Bradykinin B2 Receptor Antagonist (Firazyr) Market, 2013-2018
Figure Selective Bradykinin B2 Receptor Antagonist (Firazyr) Market Size and Growth, 2015-2019 (USD Million)
Figure Selective Bradykinin B2 Receptor Antagonist (Firazyr) Market Size and Growth, 2015-2019 (in Volume)
Table Selective Bradykinin B2 Receptor Antagonist (Firazyr) CAGR by Revenue and Volume, 2015-2019
4.2 Market Forecast
4.2.1 C1-inhibitors Market Forecast, 2020-2025
Figure C1-inhibitors Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure C1-inhibitors Market Estimates and Forecasts, 2020-2025 (in Volume)
Table C1-inhibitors CAGR by Revenue and Volume, 2012-2024
4.2.2 Kallikrein Inhibitor (Kalbitor) Market Forecast, 2020-2025
Figure Kallikrein Inhibitor (Kalbitor) Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Kallikrein Inhibitor (Kalbitor) Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Kallikrein Inhibitor (Kalbitor) CAGR by Revenue and Volume, 2012-2024
4.2.3 Selective Bradykinin B2 Receptor Antagonist (Firazyr) Market Forecast, 2020-2025
Figure Selective Bradykinin B2 Receptor Antagonist (Firazyr) Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Selective Bradykinin B2 Receptor Antagonist (Firazyr) Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Selective Bradykinin B2 Receptor Antagonist (Firazyr) CAGR by Revenue and Volume, 2012-2024
5 Market Segmentation by Application
5.1 Market Size
5.1.1 Hospital Pharmacies Market, 2013-2018
Figure Hospital Pharmacies Market Size and Growth, 2015-2019 (USD Million)
Figure Market Size and Growth, 2015-2019 (in Volume)
Table Hospital Pharmacies CAGR by Revenue and Volume, 2015-2019
5.1.2 Independent Pharmacies and Outlets Market, 2013-2018
Figure Independent Pharmacies and Outlets Market Size and Growth, 2015-2019 (USD Million)
Figure Market Size and Growth, 2015-2019 (in Volume)
Table Independent Pharmacies and Outlets CAGR by Revenue and Volume, 2015-2019
5.2 Market Forecast
5.2.1 Hospital Pharmacies Market Forecast, 2020-2025
Figure Hospital Pharmacies Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Hospital Pharmacies Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Hospital Pharmacies CAGR by Revenue and Volume, 2020-2025
5.2.2 Independent Pharmacies and Outlets Market Forecast, 2020-2025
Figure Independent Pharmacies and Outlets Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Independent Pharmacies and Outlets Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Independent Pharmacies and Outlets CAGR by Revenue and Volume, 2020-2025
6 Market Segmentation by Region
6.1 Market Size
6.1.1 Asia-Pacific
6.1.1.1 Asia-Pacific Market, 2015-2019
Figure Asia-Pacific Market Size and Growth, 2015-2019 (USD Million)
Figure Asia-Pacific Market Size and Growth, 2015-2019 (in Volume)
Table Asia-Pacific CAGR by Revenue and Volume, 2015-2019
6.1.1.2 Asia-Pacific Market by Type
Figure Asia-Pacific Market Size by Type
Figure Asia-Pacific Market Share by Type
6.1.1.3 Asia-Pacific Market by Application
Figure Asia-Pacific Market Size by Application
Figure Asia-Pacific Market Share by Application
6.1.2 North America
6.1.2.1 North America Market, 2015-2019
Figure North America Market Size and Growth, 2015-2019 (USD Million)
Figure North America Market Size and Growth, 2015-2019 (in Volume)
Table North America CAGR by Revenue and Volume, 2015-2019
6.1.2.2 North America Market by Type
Figure North America Market Size by Type
Figure North America Market Share by Type
6.1.2.3 North America Market by Application
Figure North America Market Size by Application
Figure North America Market Share by Application
6.1.3 Europe
6.1.3.1 Europe Market, 2015-2019
Figure Europe Market Size and Growth, 2015-2019 (USD Million)
Figure Europe Market Size and Growth, 2015-2019 (in Volume)
Table Europe CAGR by Revenue and Volume, 2015-2019
6.1.3.2 Europe Market by Type
Figure Europe Market Size by Type
Figure Europe Market Share by Type
6.1.3.3 Europe Market by Application
Figure Europe Market Size by Application
Figure Europe Market Share by Application
6.1.4 South America
6.1.4.1 South America Market, 2015-2019
Figure South America Market Size and Growth, 2015-2019 (USD Million)
Figure South America Market Size and Growth, 2015-2019 (in Volume)
Table South America CAGR by Revenue and Volume, 2015-2019
6.1.4.2 South America Market by Type
Figure South America Market Size by Type
Figure South America Market Share by Type
6.1.4.3 South America Market by Application
Figure South America Market Size by Application
Figure South America Market Share by Application
6.1.5 Middle East & Africa
6.1.5.1 Middle East & Africa Market, 2015-2019
Figure Middle East & Africa Market Size and Growth, 2015-2019 (USD Million)
Figure Middle East & Africa Market Size and Growth, 2015-2019 (in Volume)
Table Middle East & Africa CAGR by Revenue and Volume, 2015-2019
6.1.5.2 Middle East & Africa Market by Type
Figure Middle East & Africa Market Size by Type
Figure Middle East & Africa Market Share by Type
6.1.5.3 Middle East & Africa Market by Application
Figure Middle East & Africa Market Size by Application
Figure Middle East & Africa Market Share by Application
6.2 Market Forecast
6.2.1 Asia-Pacific Market Forecast, 2020-2025
Figure Asia-Pacific Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Asia-Pacific Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Asia-Pacific CAGR by Revenue and Volume, 2020-2025
6.2.2 North America Market Forecast, 2020-2025
Figure North America Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure North America Market Estimates and Forecasts, 2020-2025 (in Volume)
Table North America CAGR by Revenue and Volume, 2020-2025
6.2.3 Europe Market Forecast, 2020-2025
Figure Europe Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Europe Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Europe CAGR by Revenue and Volume, 2020-2025
6.2.4 South America Market Forecast, 2020-2025
Figure South America Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure South America Market Estimates and Forecasts, 2020-2025 (in Volume)
Table South America CAGR by Revenue and Volume, 2020-2025
6.2.5 Middle East & Africa Market Forecast, 2020-2025
Figure Middle East & Africa Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Middle East & Africa Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Middle East & Africa CAGR by Revenue and Volume, 2020-2025
7 Market Competitive
7.1 Global Market by Vendors
Table Global Plasma Protease C1-inhibitor Treatment Market by Vendors, 2015-2019 (in Volume)
Table Global Plasma Protease C1-inhibitor Treatment Market Share by Vendors, 2015-2019 (USD Million)
Table Global Plasma Protease C1-inhibitor Treatment Market Share by Vendors, 2015-2019 (in Volume)
7.2 Market Concentration
Figure Plasma Protease C1-inhibitor Treatment Market Concentration by Region
7.3 Price & Factors
Table Price Factors List
7.4 Marketing Channel
Figure Marketing Channels Overview
8 Major Vendors
8.1 Shire plc
Table Shire plc Profile List
Table Microecological Modulator Operating Data of Shire plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.2 CSL Limited
Table CSL Limited Profile List
Table Microecological Modulator Operating Data of CSL Limited (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.3 Sanquin
Table Sanquin Profile List
Table Microecological Modulator Operating Data of Sanquin (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.4 Pharming Group N.V.
Table Pharming Group N.V. Profile List
Table Microecological Modulator Operating Data of Pharming Group N.V. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9 Conclusion
Table Product Specifications of Plasma Protease C1-inhibitor Treatment
Table Products Segment of Plasma Protease C1-inhibitor Treatment
Table Global Plasma Protease C1-inhibitor Treatment Market by Type, 2011-2022 (USD Million)
Table C1-inhibitors Overview
Table Kallikrein Inhibitor (Kalbitor) Overview
Table Selective Bradykinin B2 Receptor Antagonist (Firazyr) Overview
Table Application Segment of Plasma Protease C1-inhibitor Treatment
Table Global Plasma Protease C1-inhibitor Treatment Market by Application, 2011-2022 (USD Million)
Table Hospital Pharmacies Overview
Table Independent Pharmacies and Outlets Overview
Table Global Plasma Protease C1-inhibitor Treatment Market by Region, 2011-2022 (USD Million)
Table Cost of Plasma Protease C1-inhibitor Treatment
Table Market Dynamics
Table Policy of Plasma Protease C1-inhibitor Treatment
Table GDP of Major Countries
Table Technology of Plasma Protease C1-inhibitor Treatment
Table Market Entry of Plasma Protease C1-inhibitor Treatment
Table C1-inhibitors CAGR by Revenue and Volume, 2015-2019
Table Kallikrein Inhibitor (Kalbitor) CAGR by Revenue and Volume, 2015-2019
Table Selective Bradykinin B2 Receptor Antagonist (Firazyr) CAGR by Revenue and Volume, 2015-2019
Table C1-inhibitors CAGR by Revenue and Volume, 2012-2024
Table Kallikrein Inhibitor (Kalbitor) CAGR by Revenue and Volume, 2012-2024
Table Selective Bradykinin B2 Receptor Antagonist (Firazyr) CAGR by Revenue and Volume, 2012-2024
Table Hospital Pharmacies CAGR by Revenue and Volume, 2015-2019
Table Independent Pharmacies and Outlets CAGR by Revenue and Volume, 2015-2019
Table Hospital Pharmacies CAGR by Revenue and Volume, 2020-2025
Table Independent Pharmacies and Outlets CAGR by Revenue and Volume, 2020-2025
Table Asia-Pacific CAGR by Revenue and Volume, 2015-2019
Table North America CAGR by Revenue and Volume, 2015-2019
Table Europe CAGR by Revenue and Volume, 2015-2019
Table South America CAGR by Revenue and Volume, 2015-2019
Table Middle East & Africa CAGR by Revenue and Volume, 2015-2019
Table Asia-Pacific CAGR by Revenue and Volume, 2020-2025
Table North America CAGR by Revenue and Volume, 2020-2025
Table Europe CAGR by Revenue and Volume, 2020-2025
Table South America CAGR by Revenue and Volume, 2020-2025
Table Middle East & Africa CAGR by Revenue and Volume, 2020-2025
Table Global Plasma Protease C1-inhibitor Treatment Market by Vendors, 2015-2019 (in Volume)
Table Global Plasma Protease C1-inhibitor Treatment Market Share by Vendors, 2015-2019 (USD Million)
Table Global Plasma Protease C1-inhibitor Treatment Market Share by Vendors, 2015-2019 (in Volume)
Table Price Factors List
Table Shire plc Profile List
Table Microecological Modulator Operating Data of Shire plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table CSL Limited Profile List
Table Microecological Modulator Operating Data of CSL Limited (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sanquin Profile List
Table Microecological Modulator Operating Data of Sanquin (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Pharming Group N.V. Profile List
Table Microecological Modulator Operating Data of Pharming Group N.V. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
